Featured

FDA Approves KERENDIA® (finerenone) for Heart Failure with LVEF ≥40%

The U.S. Food and Drug Administration (FDA) has approved KERENDIA® (finerenone) to treat heart failure (HF) with left ventricular ejection fraction (L...

Home/KnolSights/Regulatory Approvals/FDA Approves KERENDIA® (finerenone) for Heart Failure with LVEF ≥40%